Evaluation of Circulating Tumor DNA as a Biomarker for Chemoresistance in Colorectal Cancer

Background: Colorectal cancer (CRC) is a leading cause of cancer-related mortality globally. Resistance to chemotherapy, particularly to first-line regimens such as FOLFOX (5-fluorouracil, leucovorin, and oxaliplatin), remains a critical barrier to successful treatment. Methods: This prospective obs...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Koduvayur Roopa Lakshmi, Charan Sankar Sankaranarayanan, Raja A. S. Gogineni, K. Afsar Shaheen, Parasharan Peddi
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wolters Kluwer Medknow Publications 2025-12-01
Edice:	Journal of Pharmacy and Bioallied Sciences
Témata:	biomarker chemoresistance colorectal cancer
On-line přístup:	https://journals.lww.com/10.4103/jpbs.jpbs_1319_25
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!